Candida krusei arthritis in a patient with hematologic malignancy: Successful treatment with voriconazole

Clinical Infectious Diseases

Volumn 45, Issue 7, 2007, Pages 897-898

  Sili, U ^a   Yilmaz, M ^a   Ferhanoglu, B ^a   Mert, Ali ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; FLUCONAZOLE; TEICOPLANIN; VORICONAZOLE; ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTHROCENTESIS; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANDIDA KRUSEI; CASE REPORT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTIOUS ARTHRITIS; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; URINALYSIS; URINE CULTURE; CANDIDA; DRUG EFFECT; KNEE; LYMPHOSARCOMA; MICROBIOLOGY; MIDDLE AGED; MYCOSIS; PATHOGENICITY; SYNOVIAL FLUID;

ANTIFUNGAL AGENTS; ARTHRITIS, INFECTIOUS; CANDIDA; HUMANS; KNEE JOINT; LYMPHOMA, B-CELL; LYMPHOMA, DIFFUSE; MALE; MIDDLE AGED; MYCOSES; PYRIMIDINES; SYNOVIAL FLUID; TRIAZOLES;

EID: 34848844347     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521253     Document Type: Article

References (13)

1. Edwards JE Jr. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier, 2005:2938-57.
2. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50:243-60.
3. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325:1274-7.
4. Miller DJ, Mejicano GC. Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 2001; 33:523-30.
5. Vicari P, Feitosa PR, Chauffaille ML, Yamamoto M, Figueiredo MS. Septic arthritis as the first sign of Candida tropicalis fungaemia in an acute lymphoid leukemia patient. Braz J Infect Dis 2003; 7:426-8.
6. Lin MY, Carmeli Y, Zumsteg J, et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother 2005; 49:4555-60.
7. Kohli R, Hadley S. Fungal arthritis and osteomyelitis. Infect Dis Clin North Am 2005; 19:831-51.
8. Nguyen VQ, Penn RL. Candida krusei infectious arthritis: a rare complication of neutropenia. Am J Med 1987; 83:963-5.
9. Sim JP, Kho BC, Liu HS, Yung R, Chan JC. Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin. Hong Kong Med J 2005; 11:120-3.
10. Wang HP, Yen YF, Chen WS, et al. An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy. Clin Rheumatol 2006; 26:1195-7.
11. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-89.
12. Canton E, Peman J, Gobernado M, Viudes A, Espinel-Ingroff A. Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob Agents Chemother 2004; 48:2477-82.
13. Silveira LH, Cuellar ML, Citera G, Cabrera GE, Scopelitis E, Espinoza LR. Candida arthritis. Rheum Dis Clin North Am 1993; 19:427-37.